Astec LifeSciences Limited — Important, 26-03-2025: General Updates

Astec LifeSciences Limited has announced a board meeting regarding the payment of interest and the prepayment of a full redemption amount concerning its Non-Convertible Debentures (NCDs) with an issue size of ₹49 crore. An interest payment of ₹2.44 crore was made, with the actual payment date also being today. The redemption of ₹49 crore for 4,900 NCDs has been executed, leaving no outstanding amount against these securities.

This proactive approach to managing debt positions the company favorably, potentially bolstering investor confidence. The completed payment signifies financial health, likely leading to a positive outlook among investors.